Research & Consultant Companies

Pharmaceutical innovation traditionally hides behind narratives that justify exorbitant drug prices based on high development costs. However, this perception neglects the critical role of...

The European Medicines Agency (EMA) convened a pivotal meeting with stakeholders to address the future of pharmaceutical policies. Held both online and in-person, this...

The recent HMA-EMA joint Network Data Steering Group meeting, held virtually, charted a critical course for future data standardisation and regulatory strategies under its...

The increasing integration of Artificial Intelligence (AI) within pharmaceutical and biotechnology sectors necessitates a robust regulatory framework to guide its application. Industry leaders and...

As medical practices edge towards more personalized prevention strategies, the application of PSA-based screenings for early prostate cancer detection is gaining attention. Though not...

Advancements in the battle against cancer have ignited fresh interest, especially with promising therapies altering current paradigms. In the complex landscape of lung cancer...

Austria is spearheading an innovative approach to healthcare with the development of a programme theory for social prescribing (SP) in primary care environments. Implemented...

The collaborative digital landscape in European regulatory affairs sees a pivotal moment as the European Medicines Agency (EMA) and the Heads of Medicines Agencies...

As digital technologies evolve, healthcare regulators face increasing demands to integrate real-world data into regulatory decision-making processes. This is a critical undertaking as it...

Leaders from across medical regulatory bodies are steering transformative dialogue and decisions within the HMA-EMA joint Network Data Steering Group. With emerging topics such...

Digital health technologies are stepping into the spotlight, offering new pathways for parents to tackle perinatal mental health risks. With up to 20% of...

A glaring gap in Finland's healthcare system has been spotlighted. Finland lags behind its Nordic counterparts by not screening newborns for Spinal Muscular Atrophy...

Leber's hereditary optic neuropathy (LHON), a condition that leads to the gradual loss of vision, primarily affects adolescents and adults who have mitochondrial mutations....

Multiple myeloma, a complex cancer affecting plasma cells in the bone marrow, continues to challenge medical researchers as they seek effective treatments. Despite existing...

Amid significant developments, the European Union has withdrawn the orphan medicinal product designation for a treatment aimed at diffuse large B-cell lymphoma (DLBCL), effective...